The Rules for ensuring the provision of medical care (if necessary outside the Russian Federation) to a specific child with a serious life-threatening or chronic disease, including a rare (orphan) disease, or to groups of such children (hereinafter – the “Rules”) were approved by Decree of the Government of Russia dated May 21, 2021 No. 769.
A draft order of the Ministry of Health has been developed “On Amending the List of Diseases and Conditions and Corresponding Medicines Containing Narcotic Drugs or Psychotropic Substances in order to import them into the territory of the Russian Federation for the provision of health care according to the vital indications of a specific patient or group of patients, approved by the order of the Ministry Healthcare of the Russian Federation No. 80n dated February 13, 2020”.
Decree of the Government of Russia dated 06.04.2021 No. 545 approved the Procedure for the acquisition of medicinal products, medical devices and technical means of rehabilitation for a specific child with a serious life-threatening and chronic disease, including a rare (orphan) disease, or for groups of such children (hereinafter referred to as the “Procedure”).
Resolution of the Government of Russia dated April 30, 2021, No. 687 “On state support of organizations to compensate for part of the costs associated with the certification of products, including products of the pharmaceutical and medical industry, in foreign markets” (hereinafter – “Resolution No. 687”) sets goals, conditions and procedure the provision of subsidies from the federal budget to organizations to compensate for part of the costs associated with the certification of products, including products of the pharmaceutical and medical industry, in foreign markets, within the framework of the federal project “Industrial Export” of the national project “International Cooperation and Export”.
The Russian Ministry of Health has developed a draft Rules for the Dispensing of Medicines for Medical Use” (project ID 01/02 / 04-21 / 00114788) (hereinafter referred to as the Rules).
- Roman Shabrov, attorney at BRACE, spoke at the PHARMAPAK forum
- The courts have determined the interchangeability of the drug “Kashnol” on the basis of data from the State Register of Medicines
- Webinar on the topic: “The practice of reducing costs and risks during transportation and storage of medicinal products”
- The rules for the destruction of seized falsified, substandard and counterfeit medical devices have been approved
Earlier articles
Latest news
Digest of the Russian pharmaceutical industry in the 2nd quarter of 2023
28-07-2023
Among the most important changes in the regulation of the Russian pharmaceutical industry in the 2nd quarter of 2023, are the following: :
Digest of regulation of international trade in Russia in the 1st quarter of 2023
17-05-2023
Among the most important changes in the regulation of foreign economic activity in the 1st quarter of 2023, the following can be distinguished:
Digest of the Russian pharmaceutical industry in the 1st quarter of 2023
12-05-2023
Among the most important changes in the regulation of the Russian pharmaceutical industry in the 1st quarter of 2023, the following can be distinguished:
Roman Shabrov, attorney at law and partner at BRACE commented on the case of an anticompetitive agreement in the antiseptic market
21-02-2022
Roman Shabrov, partner at BRACE commented for Pharmaceutical Bulletin magazine on the case of an anti-competitive agreement on the Chlorhexedine antiseptic market, identified by the FAS Russia, the resolution of which was appealed by the companies held liable.
The Eurasian Economic Commission recalls the registration of medicines according to the rules of the EAEU
11-08-2021
In July 2021, the Eurasian Economic Commission issued an update that from July 1, 2021, medicinal products should be registered according to the unified rules of the EAEU. These rules were approved by the Decision of the Council of the Economic Commission dated 03.01.2017 No. 78 “On the rules for registration and examination of medicines for medical use”. At the same...
The Ministry of Health has allowed the use of personal medicines of patients in inpatient treatment
11-08-2021
Recall that earlier by Appendix No. 5 to the Rules of Compulsory Medical Insurance, approved by order of the Ministry of Health of the Russian Federation No. 108n dated February 28, 2019, determining the coefficients of the amount of non-payment or incomplete payment of the costs of a medical organization for the provision of medical care as a basis for...
